# NeuroTherapia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurotherapia

- Industry: Biotechnology
- Headquarters: Cleveland, US
- Website: www.neurotherapia.com
- Total disclosed funding: $21M
- Latest round: Series B (Aug 6, 2024)
- Investors on record: 7

## About

Founded in 2015 and based in Ohio, US, NeuroTherapia, Inc. operates as a clinical-stage company that focuses on developing new chemical entities for the treatment of neuroinflammatory diseases. The company was co-founded by Drs. Mohamed Naguib and Joseph Foss. As of 2024, the company is headed by its CEO Tony Giordano. In August 2024, NeuroTherapia, Inc. raised USD 12.3 million in series B funding led by new investors Cleveland Clinic Ventures, with participation from returning investors, Brain Trust Accelerator Fund, Dolby Family Ventures and the Alzheimer’s Drug Discovery Foundation. New investors Foundation for a Better World and CRUINT also participated in the round.

The firm concentrated on creating small molecule oral medicines that target known CNS inflammatory drivers, microglia cells. The company's main initiative, NTRX-07, is a tiny chemical that may be taken orally that is intended to improve learning and memory by enhancing neuroplasticity and reducing inflammation.

The company plans to us the August 2024 funding to support the ongoing clinical development of its oral cannabinoid receptor agonist NTRX-07, which is being developed to treat Alzheimer's disease.

## Funding rounds

- Series B, Aug 6, 2024, $12M — Brain Trust Accelerator Fund, Dolby Family Ventures, Alzheimer's Drug Discovery Foundation, Cleveland Clinic Ventures, Foundation for a Better World, CRUINT
- Series A, Sep 22, 2020, $8.8M — Cleveland Clinic Foundation, Brain Trust Accelerator Fund, Dolby Family Ventures, Alzheimer's Drug Discovery Foundation

## Investors

- Cleveland Clinic Foundation — Series A
- Brain Trust Accelerator Fund (https://capitalatlas.ai/funds/brain-trust-accelerator-fund) — Series A, Series B
- Dolby Family Ventures (https://capitalatlas.ai/funds/dolby-family-ventures) — Series A, Series B
- Alzheimer's Drug Discovery Foundation — Series A, Series B
- Cleveland Clinic Ventures (https://capitalatlas.ai/funds/cleveland-clinic-ventures) — Series B
- Foundation for a Better World — Series B
- CRUINT — Series B